Cardiovascular (CV) Risk Clinical Trials

12 recruiting

Cardiovascular (CV) Risk Trials at a Glance

12 actively recruiting trials for cardiovascular (cv) risk are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Besançon, Bethesda, and Bologna. Lead sponsors running cardiovascular (cv) risk studies include Elsan, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, and Duke University.

Browse cardiovascular (cv) risk trials by phase

Treatments under study

About Cardiovascular (CV) Risk Clinical Trials

Looking for clinical trials for Cardiovascular (CV) Risk? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cardiovascular (CV) Risk trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cardiovascular (CV) Risk clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women

Cardiovascular (CV) Risk
National Heart, Lung, and Blood Institute (NHLBI)250 enrolled1 locationNCT04014348
Recruiting

The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women

Body CompositionMenopauseCardiovascular (CV) Risk+2 more
University of California, San Francisco90 enrolled1 locationNCT07284082
Recruiting
Not Applicable

Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arthritis

Cardiovascular (CV) RiskAerobic ExerciseChronic Kidney Disease+1 more
Jérôme Bouchan90 enrolled1 locationNCT07469540
Recruiting
Not Applicable

Weight Management After Cancer for Survivors in Rural Communities

Breast CancerBreast Cancer SurvivorshipWeight Management+1 more
Duke University40 enrolled3 locationsNCT07426952
Recruiting

Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications

Cardiovascular (CV) RiskPreeclampsia (PE)Fetal Weight
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1,260 enrolled1 locationNCT07356817
Recruiting

Diet and Cardiometabolism in Rosario

Cardiovascular (CV) RiskNutritionCardiometabolic Health Indicators
Universidad del Centro Educativo Latinoamericano105 enrolled2 locationsNCT07247487
Recruiting

Identification of Asymptomatic Patients at Very High Cardiovascular Risk: Contribution of a Strategy Based on Carotid and Coronary Explorations, Compared to Simple Risk Calculation Using the European "SCORE 2" Algorithm. (IDEA-CVR)

Cardiovascular (CV) RiskCholesterolAtheroma+1 more
Elsan1,000 enrolled1 locationNCT07252830
Recruiting

Multimorbidity and Cardiovascular Risk Factors After Renal Transplant

Cardiovascular (CV) RiskKidney TransplantMultimorbidity
University Hospitals of Derby and Burton NHS Foundation Trust30 enrolled1 locationNCT07205692
Recruiting
Not Applicable

Improving the Heart Health of Home Health Aides

Cardiovascular (CV) RiskCardiovascular
Weill Medical College of Cornell University40 enrolled2 locationsNCT07067398
Recruiting

Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

Cardiovascular (CV) RiskCardiovascular Disease PreventionCardiovascular Disease (CVD)+4 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna500 enrolled1 locationNCT07187947
Recruiting
Not Applicable

The Role of Mobile Apps in Promoting Cardiovascular Health and Motivation to Exercise During Pregnancy

ExerciseCardiovascular (CV) Risk
Old Dominion University50 enrolled1 locationNCT07166822
Recruiting
Not Applicable

Pulses: Optimizing Pulse Consumption for Cardiometabolic Health

Cardiovascular (CV) RiskHbA1cLipid Profile+2 more
University of Arizona180 enrolled2 locationsNCT06861153